ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB: ACTC) names Pedro Huertas, MD, PhD, as Chief Development Officer responsible for overseeing the development of the Company’s programs to create novel stem cell-based therapeutics, from the pre-clinical stage through clinical development and regulatory approval.
